140 related articles for article (PubMed ID: 31114346)
21. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
22. Intratumoral CCR5
Xiang Z; Zhou Q; Zeng H; Wang Z; Zhang H; Liu Z; Huang Q; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Wang J; Guo J; Xu J
Oncoimmunology; 2020 Aug; 9(1):1802176. PubMed ID: 32923162
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
Chung YR; Kim HJ; Jang MH; Park SY
Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
[TBL] [Abstract][Full Text] [Related]
24.
Pignot G; Le Goux C; Vacher S; Schnitzler A; Radvanyi F; Allory Y; Lallemand F; Delongchamps NB; Zerbib M; Terris B; Damotte D; Bieche I
Oncol Lett; 2019 Oct; 18(4):3471-3480. PubMed ID: 31516565
[TBL] [Abstract][Full Text] [Related]
25. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
26. T-helper 1 immunoreaction influences survival in muscle-invasive bladder cancer: proof of concept.
Ingels A; Sanchez Salas RE; Ravery V; Fromont-Hankard G; Validire P; Patard JJ; Pignot G; Prapotnich D; Olivier F; Galiano M; Barret E; Rozet F; Weber N; Cathelineau X
Ecancermedicalscience; 2014; 8():486. PubMed ID: 25525464
[TBL] [Abstract][Full Text] [Related]
27. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
28. Identification of miR-200c and miR141-Mediated lncRNA-mRNA Crosstalks in Muscle-Invasive Bladder Cancer Subtypes.
Liu G; Chen Z; Danilova IG; Bolkov MA; Tuzankina IA; Liu G
Front Genet; 2018; 9():422. PubMed ID: 30323832
[TBL] [Abstract][Full Text] [Related]
29. Significance of CLASP2 expression in prognosis for muscle-invasive bladder cancer patients: A propensity score-based analysis.
Chen L; Xiong W; Guo W; Su S; Qi L; Zhu B; Mo M; Jiang H; Li Y
Urol Oncol; 2019 Oct; 37(10):800-807. PubMed ID: 31130343
[TBL] [Abstract][Full Text] [Related]
30. mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer.
Le Goux C; Vacher S; Pignot G; Sibony M; Barry Delongchamps N; Terris B; Piaggio E; Zerbib M; Damotte D; Bieche I
Oncoimmunology; 2017; 6(11):e1358330. PubMed ID: 29147616
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
Li J; Wang J; Chen R; Bai Y; Lu X
Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
[TBL] [Abstract][Full Text] [Related]
32. Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.
Hoesli R; Birkeland AC; Rosko AJ; Issa M; Chow KL; Michmerhuizen NL; Mann JE; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; McHugh JB; Brenner JC; Spector ME
Oral Oncol; 2018 Feb; 77():83-89. PubMed ID: 29362129
[TBL] [Abstract][Full Text] [Related]
33. Identification of The Immune Subtype Among Muscle-invasive Bladder Cancer Patients by Multiple Datasets.
Shinwari K; Chen Z; Liu G; Chen L; Bolkov MA; Tuzankina IA; Chereshnev VA
Acta Med Indones; 2022 Jan; 54(1):62-71. PubMed ID: 35398827
[TBL] [Abstract][Full Text] [Related]
34. Robust Prognostic Subtyping of Muscle-Invasive Bladder Cancer Revealed by Deep Learning-Based Multi-Omics Data Integration.
Zhang X; Wang J; Lu J; Su L; Wang C; Huang Y; Zhang X; Zhu X
Front Oncol; 2021; 11():689626. PubMed ID: 34422643
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
[TBL] [Abstract][Full Text] [Related]
37. Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies.
Viveiros N; Flores BC; Lobo J; Martins-Lima C; Cantante M; Lopes P; Deantonio C; Palu C; Sainson RC; Henrique R; Jerónimo C
Clin Transl Immunology; 2022; 11(9):e1402. PubMed ID: 36092481
[TBL] [Abstract][Full Text] [Related]
38. Utility of SAM68 in the progression and prognosis for bladder cancer.
Zhang Z; Yu C; Li Y; Jiang L; Zhou F
BMC Cancer; 2015 May; 15():364. PubMed ID: 25944080
[TBL] [Abstract][Full Text] [Related]
39. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.
Horn T; Laus J; Seitz AK; Maurer T; Schmid SC; Wolf P; Haller B; Winkler M; Retz M; Nawroth R; Gschwend JE; Kübler HR; Slotta-Huspenina J
World J Urol; 2016 Feb; 34(2):181-7. PubMed ID: 26055646
[TBL] [Abstract][Full Text] [Related]
40. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
